Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€321.10
15.08.20
-
16.10.20
12.64%
16.10.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
€600.00
15.10.20
-1.81%
15.10.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€264.80
05.06.20
€290.00
12.10.20
5.70%
12.10.20

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Anthem Inc.

Start price
Target price
Perf. (%)
€248.65
04.05.20
€275.00
12.10.20
1.45%
12.10.20

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€207.40
25.08.20
€225.00
21.09.20
-1.23%
21.09.20

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.72
09.08.20
€65.00
26.08.20
-5.53%
26.08.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.80
20.05.20
€60.00
25.05.20
4.09%
25.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Allergan plc

Start price
Target price
Perf. (%)
€147.75
26.06.19
€180.40
11.05.20
0.00%
11.05.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.45
30.04.20
€85.00
04.05.20
-5.28%
04.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.38
20.12.19
€86.00
23.04.20
21.40%
23.04.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€74.99
04.04.20
-
18.04.20
5.08%
18.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€81.44
31.03.20
€95.00
08.04.20
10.79%
08.04.20

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.00
21.03.20
-
04.04.20
3.16%
04.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€62.80
23.03.20
€70.00
23.03.20
-5.86%
23.03.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.81
19.03.20
€85.00
19.03.20
-3.91%
19.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€124.68
01.03.19
€130.79
11.03.20
-5.54%
11.03.20

Could be worthwhile Investment >10% per year
buy
Zimmer Holdings

Start price
Target price
Perf. (%)
€124.78
03.09.19
€155.00
10.03.20
-17.45%
10.03.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€71.88
14.01.18
€85.69
20.12.19
-17.39%
20.12.19

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€98.78
13.10.19
€120.00
26.10.19
0.30%
26.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative